A magnetic chitosan hydrogel for sustained and prolonged delivery of Bacillus Calmette-Guerin in the treatment of bladder cancer

被引:119
作者
Zhang, Dong [1 ]
Sun, Peng [1 ]
Li, Peng [1 ]
Xue, Aibing [1 ]
Zhang, Xiaokai [2 ]
Zhang, Haiyang [1 ,3 ]
Jin, Xunbo [1 ]
机构
[1] Shandong Univ, Shandong Prov Hosp, Minimally Invas Urol Ctr, Jinan 250021, Peoples R China
[2] Shandong Normal Univ, Coll Phys & Elect, Electron Microscope Lab, Jinan 250014, Peoples R China
[3] Univ Calif San Francisco, Sch Med, Dept Urol, Knuppe Mol Urol Lab, San Francisco, CA 94143 USA
基金
中国国家自然科学基金; 国家高技术研究发展计划(863计划);
关键词
Bacillus Calmette-Guerin; Intravesical instillation; Chitosan; Magnetic nanoparticle; Thermosensitive hydrogel; Intravesical drug delivery; DRUG-DELIVERY; INTRAVESICAL IMMUNOTHERAPY; THERMOSENSITIVE HYDROGEL; UROTHELIAL CARCINOMA; BCG IMMUNOTHERAPY; CHEMOTHERAPY; SYSTEM; NANOPARTICLES; INSTILLATION; DOXORUBICIN;
D O I
10.1016/j.biomaterials.2013.09.027
中图分类号
R318 [生物医学工程];
学科分类号
0831 ;
摘要
The aim of this study was to develop a magnetic thermosensitive hydrogel as intravesical Bacillus Calmette-Guerin (BCG) delivery system, which was formulated with chitosan (CS), beta-glycerophosphate (GP) and Fe3O4 magnetic nanoparticle (Fe3O4-MNP). The gelation time and magnetic response of the gel system were investigated. The morphology of the gel was displayed by scanning electron microscope. Frozen section examination was creatively employed for exhibiting the structure of the gel and determining its intravesical residence time. The antitumor effect and local immune activity of BCG loaded magnetic gel were evaluated. The flowing solution of CS/GP under room temperature could gelate rapidly at body temperature both in vitro and in vivo. The magnetic injectable hydrogels significantly prolonged intravesical BCG residence time under an applied magnetic field. In comparison to traditional BCG therapy for superficial bladder tumor, BCG delivered by the gel system induced a stronger Th1 immune response and revealed higher antitumor efficacy. (C) 2013 Elsevier Ltd. All rights reserved.
引用
收藏
页码:10258 / 10266
页数:9
相关论文
共 39 条
[1]   EAU Guidelines on Non-Muscle-invasive Urothelial Carcinoma of the Bladder: Update 2013 [J].
Babjuk, Marko ;
Burger, Maximilian ;
Zigeuner, Richard ;
Shariat, Shahrokh F. ;
van Rhijn, Bas W. G. ;
Comperat, Eva ;
Sylvester, Richard J. ;
Kaasinen, Eero ;
Boehle, Andreas ;
Palou Redorta, Joan ;
Roupret, Morgan .
EUROPEAN UROLOGY, 2013, 64 (04) :639-653
[2]   Docetaxel-loaded thermoresponsive conjugated linoleic acid-incorporated poloxamer hydrogel for the suppression of peritoneal metastasis of gastric cancer [J].
Bae, Woo Kyun ;
Park, Myong Suk ;
Lee, Ji Hee ;
Hwang, Jun Eul ;
Shim, Hyun Jeong ;
Cho, Sang Hee ;
Kim, Dae-Eun ;
Ko, Hyang Mi ;
Cho, Chong-Su ;
Park, In-Kyu ;
Chung, Ik-Joo .
BIOMATERIALS, 2013, 34 (04) :1433-1441
[3]   Biocompatibility of magnetic Fe3O4 nanoparticles and their cytotoxic effect on MCF-7 cells [J].
Chen, Daozhen ;
Tang, Qiusha ;
Li, Xiangdong ;
Zhou, Xiaojin ;
Zang, Jia ;
Xue, Wen-qun ;
Xiang, Jing-ying ;
Guo, Cai-qin .
INTERNATIONAL JOURNAL OF NANOMEDICINE, 2012, 7 :4973-4982
[4]   Preclinical analyses of intravesical chemotherapy for prevention of bladder cancer progression [J].
Delto, Joan C. ;
Kobayashi, Takashi ;
Benson, Mitchell ;
McKiernan, James ;
Abate-Shen, Cory .
ONCOTARGET, 2013, 4 (02) :269-276
[5]   Celecoxib has potent antitumour effects as a single agent and in combination with BCG immunotherapy in a model of urothelial cell carcinoma [J].
Dovedi, Simon J. ;
Kirby, John A. ;
Davies, Barry R. ;
Leung, Hing ;
Kelly, John D. .
EUROPEAN UROLOGY, 2008, 54 (03) :621-630
[6]   Design and evaluation of a mucoadhesive therapeutic agent delivery system for postoperative chemotherapy in superficial bladder cancer [J].
Eroglu, M ;
Irmak, S ;
Acar, A ;
Denkbas, EB .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2002, 235 (1-2) :51-59
[7]  
Gong C, 2013, CURR MED CHEM, V20, P79
[8]   Intravesical drug delivery: Challenges, current status, opportunities and novel strategies [J].
GuhaSarkar, Shruti ;
Banerjee, R. .
JOURNAL OF CONTROLLED RELEASE, 2010, 148 (02) :147-159
[9]   Development of a thermoresponsive chitosan gel combined with human mesenchymal stem cells and desferrioxamine as a multimodal pro-angiogenic therapeutic for the treatment of critical limb ischaemia [J].
Hastings, Conn L. ;
Kelly, Helena M. ;
Murphy, Mary J. ;
Barry, Frank P. ;
O'Brien, Fergal J. ;
Duffy, Garry P. .
JOURNAL OF CONTROLLED RELEASE, 2012, 161 (01) :73-80
[10]   Sufficient prophylactic efficacy with minor adverse effects by intravesical instillation of low-dose bacillus Calmette-Guerin for superficial bladder cancer recurrence [J].
Irie, A ;
Uchida, T ;
Yamashita, H ;
Matsumoto, K ;
Satoh, T ;
Koh, H ;
Shimura, S ;
Iwamura, M ;
Baba, S .
INTERNATIONAL JOURNAL OF UROLOGY, 2003, 10 (04) :183-189